title: Studies presented at ASCO meeting highlight success with targeted therapies.
authors.forename: Carrie
authors.initials: C
authors.lastname: Printz
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D058990:Molecular Targeted Therapy; D009101:Multiple Myeloma / Q000188:drug therapy*; D009396:Wilms Tumor / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C546027:elotuzumab